Table 4.

Statutory wholesale and pharmacy remuneration in Croatia and in the European Union (EU) Member States, 2010*

	Statutory wholesale and pharmacy remuneration in Croatia and EU Member States
	wholesale	pharmacy
Scope:
for all medicines	AT†, BE, CZ, EE, EL, ES, HR, HU, LU, LV, PT, SI‡	AT§, BE, CY – private sector, CZ, DK║, EE, EL, ES, FI¶, HR, HU, LU, LV, PT, SI‡
for reimbursable	DE**, FR, IE††, IT, LT, PL, SK	DE**, FR, IE††, IT, LT, PL, SK, UK
for prescription-only medicines	BG, RO	BG, NL, RO, SE
for others	CY‡‡, MT§§	MT§§
Form:
linear	CY, EL, HR, IE††, IT, MT, PL, PT	CY, DK, EL, IT║║, MT, PT
regressive	AT, BE, BG, CZ, DE, EE, ES, FR, HU, LT, LV¶¶, RO, SI, SK	AT, BE, BG, CZ, EE, ES, FI, FR, HU, LT, LV¶¶, PL, RO, SE***, SK
fees	-	HR, NL, SI, UK
others	LU†††	DE‡‡‡, IE††, LU†††

*Source: Survey by the authors, information provided by members of the Pharmaceutical Pricing and Reimbursement Information network. Country abbreviations are explained in the Table 1.

†Two different schemes depending on reimbursement category.

‡Except non-reimbursable over-the-counter.

§Two different schemes for different kind of customers.

║Except over-the-counter sold outside the pharmacy.

¶Except nicotine replacement therapy sold outside the pharmacy.

**Two different schemes for prescription-only medicines and for reimbursable over-the-counter.

††For different reimbursement schemes.

‡‡For locally produced medicines.

§§For medicines in the private sector.

║║Made regressive by mandatory pharmacy discounts.

¶¶Different schemes for reimbursable and for non-reimbursable medicines.

***Plus fee for generics.

†††Linear and regressive schemes depending on the origin of the product.

‡‡‡Flat fee plus linear mark-up for prescription-only medicines, regressive for reimbursable over-the-counter.